Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint; B.E. Hansen; E. Verhey; B. Oldenburg; D.W. Hommes; M. Pierik; C. Ponsioen; H.M. Dullemen; M. Russel; A.A. van Bodegraven; C.J. van der Woude

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Translated title of the contribution: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint
, B.E. Hansen
, E. Verhey
, B. Oldenburg
, D.W. Hommes
, M. Pierik
, C. Ponsioen
, H.M. Dullemen
, M. Russel
, A.A. van Bodegraven
, C.J. van der Woude

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)
Original language	Undefined/Unknown
Pages (from-to)	292-299
Number of pages	8
Journal	Gut
Volume	63
Publication status	Published - 2014

Cite this

Dewint, P., Hansen, B. E., Verhey, E., Oldenburg, B., Hommes, D. W., Pierik, M., Ponsioen, C., Dullemen, H. M., Russel, M., van Bodegraven, A. A., & van der Woude, C. J. (2014). Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut, 63, 292-299.

@article{a4c65fe26fd341c0b77634741b4aa8b5,

title = "Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)",

author = "P. Dewint and B.E. Hansen and E. Verhey and B. Oldenburg and D.W. Hommes and M. Pierik and C. Ponsioen and H.M. Dullemen and M. Russel and \{van Bodegraven\}, A.A. and \{van der Woude\}, C.J.",

year = "2014",

language = "Undefined/Unknown",

volume = "63",

pages = "292--299",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

AU - Dewint, P.

AU - Hansen, B.E.

AU - Verhey, E.

AU - Oldenburg, B.

AU - Hommes, D.W.

AU - Pierik, M.

AU - Ponsioen, C.

AU - Dullemen, H.M.

AU - Russel, M.

AU - van Bodegraven, A.A.

AU - van der Woude, C.J.

PY - 2014

Y1 - 2014

M3 - Article

SN - 0017-5749

VL - 63

SP - 292

EP - 299

JO - Gut

JF - Gut

ER -